Literature DB >> 35153440

The superior eyelid crease approach with retroseptal dissection: A modified access to the superomedial intraconal space. Treatment of a cavernous hemangioma: Case report and literature review.

Francesco De Feudis1, Riccardo Girotto1, Paolo Balercia1.   

Abstract

The orbit can be affected by primary intraconal lesions as well as cavernous hemangiomas. This article illustrates for the first time the retroseptal dissection (RD) route combined to the superior eyelid crease approach (SECA) to treat a symptomatic hemangioma inside the superomedial intraconal space. It also reviews the main studies about the argument. A 42-year-old woman affected by a mild painful proptosis and some accommodation difficulties in her right eye. The magnetic resonance imaging revealed a soft intraconal mass in the superomedial quadrant of the right orbit. The lesion was removed performing a SECA with RD through an incision inside a natural eyelid crease. Disappearance of pain with an improvement of accommodation was reported immediately. During the whole follow-up, the visual acuity, field examinations, and ocular motility did not reveal any impairment. Our approach represents a valid, quick, not technically demanding and mini-invasive method to access the superomedial intraconal space. Finally, it gives excellent functional and cosmetic results. Copyright:
© 2021 National Journal of Maxillofacial Surgery.

Entities:  

Keywords:  Case report; literature review; proptosis; retroseptal dissection; superior eyelid crease approach; superomedial intraconal hemangioma

Year:  2021        PMID: 35153440      PMCID: PMC8820314          DOI: 10.4103/njms.NJMS_420_21

Source DB:  PubMed          Journal:  Natl J Maxillofac Surg        ISSN: 0975-5950


INTRODUCTION

Cavernous hemangiomas (CHs) are the most common benign vascular tumor of the head and neck. One of the most involved regions is the orbit. Observation is indicated in not growing asymptomatic lesions while surgical treatment is always indicated in symptomatic cases.[1] In this report, the authors present a symptomatic case of a superomedial intraconal CH, successfully treated by surgical removal through a superior eyelid crease approach (SECA). The novelty is that it has been combined it with a new pathway to reach the superomedial intraconal space: the retroseptal dissection (RD) route [Figure 1]. This case report has been reported in line with the SCARE criteria.
Figure 1

Illustration of the dissection pathway through the superior eyelid approach with retroseptal dissection to access the superomedial intraconal space. The continuous arrow shows the direction toward the space; the dashed arrow demonstrates the path once the eyelid is passed

Illustration of the dissection pathway through the superior eyelid approach with retroseptal dissection to access the superomedial intraconal space. The continuous arrow shows the direction toward the space; the dashed arrow demonstrates the path once the eyelid is passed

CASE REPORT

A 42-year-old female was referred to us because of a mild, axial, and painful proptosis in the right eyeball without visual field loss and diplopia. The patient declared only worsening at short distance accommodation in the right eye. The magnetic resonance imaging (MRI) revealed a neoplasm in the right intraconal area, behind the eyeball, dislocating the optical nerve [Figure 2a and b]. According to the neuroradiologist and our clinical evaluation, the lesion could be a hemangioma. Therefore, considering the location, the anatomic relationships and the sizes,[2] the patient was candidate to remove the tumor through a SECARD.
Figure 2

Preoperative magnetic resonance imaging with contrast showing the mass inside the superomedial intraconal space, behind the right globe, between the optic nerve and the external ocular muscles. (a) Axial T2-weighted sequences. (b) Coronal STIR sequences: the optic nerve was dislocated downward

Preoperative magnetic resonance imaging with contrast showing the mass inside the superomedial intraconal space, behind the right globe, between the optic nerve and the external ocular muscles. (a) Axial T2-weighted sequences. (b) Coronal STIR sequences: the optic nerve was dislocated downward A natural eyelid crease was chosen [Figure 3a]. A curvilinear incision <3 cm long was made through the skin and orbicularis muscle. Dissection was conducted in a plane between the orbicularis muscle and the orbital septum toward the frontal bone, until the supra-orbital and supra-trochlear nerves were exposed, lateralized, and protected [Figure 3b]. The periosteum was incised over the superior orbital rim [Figure 3c] and elevated to realize a sub-periosteal plane. The trochlea was visualized; the periorbita was entered from above in a retroseptal route, proceeding with blunt dissection through the intraorbital fat until the exposure of the tendon of the underneath superior oblique muscle. Blunt dissection was continued under the tendon toward the posterior pole of the eye, then passing in between the superior and medial rectus muscles, gently retracting them to access the superomedial intraconal space and its content. The lesion was seen as a dark red soft mass [Figure 4a] and released by the surrounding muscles, intermuscular orbital fat and finally by the optic nerve. The tumor was removed en bloc [Figure 4b] without noble structures damage. The procedure was performed in 45 minutes.
Figure 3

The superior eyelid approach with retroseptal dissection illustrated. (a) A natural eyelid was chosen (a lateral extension is possible). (b) A skin-muscle flap was developed; blunt dissection and lateralization of the supra-orbital and supra-trochlear nerves. (c) The superior orbital rim reached and the periosteum incised

Figure 4

(a) The superior eyelid crease approach with retroseptal dissection: intraoperative view of the intraconal lesion. (b) The specimen after surgical resection: the histopathological examination revealed a cavernous hemangioma

The superior eyelid approach with retroseptal dissection illustrated. (a) A natural eyelid was chosen (a lateral extension is possible). (b) A skin-muscle flap was developed; blunt dissection and lateralization of the supra-orbital and supra-trochlear nerves. (c) The superior orbital rim reached and the periosteum incised (a) The superior eyelid crease approach with retroseptal dissection: intraoperative view of the intraconal lesion. (b) The specimen after surgical resection: the histopathological examination revealed a cavernous hemangioma No visual impairment, no mydriasis, no ophthalmoplegia or any duction weakness was objectified. The intraorbital throbbing pain as well as the accommodation disturbance disappeared after surgery. The histopathological examination revealed a CH. After 3 months the MRI demonstrated complete removal of the hemangioma [Figure 5a and b]; the clinical assessment showed normal ocular motility and with an almost invisible scar hidden by the patient's own skin excess [Figure 6a and b].
Figure 5

(a and b) Postoperative magnetic resonance imaging and clinical follow-up (c and d) 3 months later. (a) Axial T2-weighted and (b) coronal postcontrast sequences demonstrating complete removal of the intraconal tumor with a normal position of the optic nerve

Figure 6

(a) Complete resolution of the initial proptosis. (b) The excellent result of the superior eyelid approach with retroseptal dissection in terms of healing of skin wound: eyelid closed with skin lifted by the operator to show the healed incision inside the patient's own skin excess

(a and b) Postoperative magnetic resonance imaging and clinical follow-up (c and d) 3 months later. (a) Axial T2-weighted and (b) coronal postcontrast sequences demonstrating complete removal of the intraconal tumor with a normal position of the optic nerve (a) Complete resolution of the initial proptosis. (b) The excellent result of the superior eyelid approach with retroseptal dissection in terms of healing of skin wound: eyelid closed with skin lifted by the operator to show the healed incision inside the patient's own skin excess

DISCUSSION

CHs are congenital low flow vascular malformations. Being slow-growing masses,[1] their most common clinical sign is painless proptosis, without motility disorders or compression of the optic nerve. If the optic nerve is compressed, progressive alterations of vision are possible until blindness. Due to orbital anatomy and its noble structures, before surgery is taken a judicious medical evaluation is needed; therefore, treatment is recommended in symptomatic cases.[34] Surgical treatment is usually definitive,[1] although rare cases of local recurrence are described in literature,[5] perhaps related to incomplete resection. The diagnosis is made by computed tomography or MRI.[2] Most of CHs occupy the lateral intraconal space with a higher morbidity than extraconal hemangiomas.[6] In this article a case of a CH in the superomedial intraconal space is described. Clinically, this CH was causing a throbbing retrobulbar pain, a mild proptosis, and disturbing accommodation. At the MRI evaluation, the lesion was dislocating downward, and laterally, the optic nerve and compressing the posterior pole of the eye. Considering the clinical and radiological features, the authors performed an upper eyelid crease access with a retro-septal dissection route (SECARD) which has not been described before, to our knowledge. It has the advantage of not requiring the violation of orbital septum, avoiding its enfeeblement and fat herniation, which could happen through the standard upper eyelid crease access. Compared to a medial approach, the SECARD is more direct to the superomedial intraconal space [Figure 1 and Figure 4a], avoiding any disinsertion and reinsertion of extraocular muscles and every matter related. Compared to an endoscopic endonasal approach, the SECARD is more conservative: it does not need demolition of the medial wall to enter the orbit, neither its reconstruction to avoid postoperative orbital volume changes with a possible enophthalmos. It does not need any middle turbinectomy and any nasal septum resection to gain adequate space for endoscopic manoeuvres. Besides, it does not require any expertise in endoscopic endonasal surgery, which is mandatory to get good outcomes and to keep risks low.[78] A lateral approach[9] was also excluded firstly because it is best suitable for reaching the lateral intraconal space,[38] secondly because external scars, bony marginotomies, heavy extraocular muscular and bulbar retractions are inevitable. Moreover, it needs dissection through important nerves and vessels which are lateral to the optic nerve,[10] to reach the medial part of the intraconal space. All these more invasive and time-consuming procedures can result in serious postoperative complications, such as strabismus (due to extraocular muscular transection and misposition), or muscle palsy (due to heavy tractions). Indeed, by a SECARD, it is possible to realize a more direct and rapid route with less muscular traction, bleeding, edema, orbital tissue dissection, morbidity and, therefore, better functional and cosmetic outcomes. Even if SECARD is an external approach which implies a skin scar, it requires only one incision, always well hidden inside a natural crease of the superior eyelid, without any bony osteotomy. It is also not technically demanding because of its similarity to the superior eyelid approach for the reduction and osteosynthesis of the frontozygomatic fractures. Therefore, with regard to its low morbidity, rapidity, brilliant esthetic, and functional results, the upper blepharoplasty approach with RD route proved to be a safe promising method for removing retrobulbar intraconal superomedial masses.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

1.  Neuronavigation-guided endoscopic endonasal excision of an intraorbital intraconal cavernous hemangioma.

Authors:  Nurperi Gazioglu; Bashar Abuzayed; Necmettin Tanriover
Journal:  J Craniofac Surg       Date:  2011-09       Impact factor: 1.046

2.  Lateral approach to intraorbital lesions: anatomic and surgical considerations.

Authors:  H Arai; K Sato; T Katsuta; A L Rhoton
Journal:  Neurosurgery       Date:  1996-12       Impact factor: 4.654

3.  A PLEA FOR LATERAL ORBITOTOMY: WITH CERTAIN MODIFICATIONS.

Authors:  H B Stallard
Journal:  Br J Ophthalmol       Date:  1960-12       Impact factor: 4.638

4.  Lateral approach to the orbit: an anatomical study.

Authors:  E Gönül; E Timurkaynak
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

5.  "Round-the-Clock" Surgical Access to the Orbit.

Authors:  Alessandro Paluzzi; Paul A Gardner; Juan C Fernandez-Miranda; Matthew J Tormenti; S Tonya Stefko; Carl H Snyderman; Joseph C Maroon
Journal:  J Neurol Surg B Skull Base       Date:  2014-09-02

Review 6.  Traditional and contemporary surgical approaches to the orbit.

Authors:  Michael R Markiewicz; R Bryan Bell
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2012-11       Impact factor: 2.802

7.  Surgical exposure of lateral orbital lesions using a coronal scalp flap and lateral orbitozygomatic approach: clinical experience.

Authors:  S Paolini; A Santoro; P Missori; A Pichierri; V Esposito; P Ciappetta
Journal:  Acta Neurochir (Wien)       Date:  2006-08-14       Impact factor: 2.216

8.  Recurrent multiple cavernous hemangiomas of the orbit in association with systemic tumors.

Authors:  Vanessa Limawararut; Garry Davis; John Crompton; Igal Leibovitch; Dinesh Selva
Journal:  Am J Ophthalmol       Date:  2006-05       Impact factor: 5.258

9.  Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1.

Authors:  Jerry A Shields; Carol L Shields; Richard Scartozzi
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.